to consider whether it can pursue US damages claims stemming from Foreign Corrupt Practices Act violations by medical device businesses Stryker and Zimmer Biomet. At the 8 December hearing before the Sixth Circuit, IMSS's counsel said that, if the lower court's decision concerning Stryker isn't overturned, t